Skip to content
Screener

Globus Medical GMED Reportable Segment — Cost, Depreciation

Similar metrics at other companies

Amkor Technology logo
AMKRReportable Segment — Depreciation cost of sales
$163.69M+13.3%
Consolidated Water Company logo
CWCOSegment Retail — Cost Of Goods And Services Sold Depreciation
$646.25K+5.3%
Intrepid Potash logo
IPICorporate Segment and Other Operating Segment — Depreciation
$2K-99.5%
Mcgrath Rentcorp logo
MGRCPortable Storage — Cost Of Goods And Services Sold Depreciation
$1.1M+6.3%
Target Hospitality logo
THAll Other Segments — Cost Of Goods And Services Sold Depreciation
$868K-1.1%
Target Hospitality logo
THGovernment — Cost Of Goods And Services Sold Depreciation
$6.4M-19.4%

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$10.93B+52.9%
Enterprise value$10.54B+49.6%
P/E20.4×+0.4×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldDepreciation.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Cost of Sales and Operating expenses:
Cost of sales(210,505)(213,162)(413,494)(379,538)
Amortization of inventory fair value step-up (a)(5,967)(6,016)
Depreciation related to cost of sales(30,934)(29,636)(62,011)(58,609)
Research and development employee-related cost(26,126)(30,101)(53,463)(55,533)
Research and development other (b)(10,194)(9,852)(19,367)(17,483)
Selling, general and administrative employee-related cost(218,357)(237,372)(445,257)(426,353)
Selling, general and administrative other (c)(55,364)(59,258)(113,797)(104,881)

Item 1. Financial Statements

FAQ

What is Globus Medical's reportable segment — cost, depreciation?
Globus Medical (GMED) reported reportable segment — cost, depreciation of $30.93M in Q2 2026.
How has Globus Medical's reportable segment — cost, depreciation changed year-over-year?
Globus Medical's reportable segment — cost, depreciation increased by 4.4% year-over-year, from $29.64M to $30.93M.
What does reportable segment — cost, depreciation mean?
Represents the systematic allocation of the cost of tangible assets, such as machinery and equipment, used in the production process of the segment. This reflects the wear and tear of capital assets over their useful lives.

Ask your AI about Globus Medical's reportable segment — cost, depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude